Taken together, our study found various TRPC5 expression level in different CTC and revealed the clinically significant CTC subgroup with high TRPC5 expression, providing a new indicator for clinical prognosis evaluation of radically resected CRC patients. This evidence concerns the gene TRPC5 and colorectal carcinoma.